Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subanesthetic Sevoflurane for Treatment-Resistant Depression: A Proof-of-Concept Trial

NCT05008939 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.

NCT NCT05008939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05008939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subanesthetic Sevoflurane for Treatment-Resistant Depression: A Proof-of-Concept Trial
Lead sponsor
Shanghai First Maternity and Infant Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2021
Completion date
March 31, 2022
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, depressive disorder, treatment-resistant